Concepedia

Solmaz Sahebjam

SS

Statistics

Publications

64

Citations

5.4K

H-Index

32

Active since

2001

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Yale University

Solmaz Sahebjam is an author at Moffitt Cancer Center specializing in medicine, oncology, and neuro-oncology.

ORCID

Publications per year

2001–2023

64

Publications

64

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

David A. Reardon, Alba A. Brandes, Antonio Omuro et al. · JAMA Oncology · 2020 · 1.5K citations · Full text

, , +17

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter

Michael Lim, Michael Weller, Ahmed Idbaïh et al. · Neuro-Oncology · 2022 · 501 citations · Full text

, , +17

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

Antonio Omuro, Gordana Vlahovic, Michael Lim et al. · Neuro-Oncology · 2017 · 488 citations · Full text

, , +17

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer

Sara M. Tolaney, Solmaz Sahebjam, Émilie Le Rhun et al. · Clinical Cancer Research · 2020 · 198 citations

, , +17

THE β-THALASSEMIA MUTATION SPECTRUM IN THE IRANIAN POPULATION

Hossein Najmabadi, Roxana Kariminejad, Solmaz Sahebjam et al. · Hemoglobin · 2001 · 157 citations

, , +12

1–5 of 64